Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis. It is administered by subcutaneous injection (injection under the skin).[42] It works by inactivating tumor necrosis factor-alpha (TNF\u03b1).<\/p>\n
If HUMIRA (adalimumab) Injection<\/strong> are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n Note:<\/strong> NEWS \/ UPDATES<\/strong><\/p>\n Humira (adalimumab) is indicated for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult and pediatric Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis. In the EU it is also indicated for chronic aggressive progressive pulmonary and bone sarcoidosis.<\/p>\n Source Details:\u00a0Patient Information<\/strong><\/a><\/p>\n If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import HUMIRA (adalimumab) Injection\u201d <\/strong> based on the information you provide.<\/p>\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.<\/p>\n\n
HUMIRA (adalimumab) Injection<\/h2>\n
\n\n
\n Brand Name:<\/strong><\/td>\n HUMIRA<\/td>\n<\/tr>\n \n Generic Name:<\/strong><\/td>\n adalimumab<\/td>\n<\/tr>\n \n Strength:<\/strong><\/td>\n \u2022 mg\/0.8 mL in a single-use prefilled pen (HUM IRA Pen)
\n\u2022 mg\/0.8 mL in a single-use prefilled glass syrnge
\n\u2022 20 mg\/OA mL in a single-use prefilled glass syringe<\/td>\n<\/tr>\n\n Manufacturer:<\/strong><\/td>\n Abbott Laboratories<\/td>\n<\/tr>\n \n Approved By:<\/strong><\/td>\n EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Access the best support services globally<\/h4>\n